NO950985L - Ikke-metaboliserbare klomifenanaloger for behandling av tamoxifenresistente tumorer - Google Patents
Ikke-metaboliserbare klomifenanaloger for behandling av tamoxifenresistente tumorerInfo
- Publication number
- NO950985L NO950985L NO950985A NO950985A NO950985L NO 950985 L NO950985 L NO 950985L NO 950985 A NO950985 A NO 950985A NO 950985 A NO950985 A NO 950985A NO 950985 L NO950985 L NO 950985L
- Authority
- NO
- Norway
- Prior art keywords
- tamoxifen
- treatment
- metabolizable
- resistant tumors
- clomiphene analogues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/45—Monoamines
- C07C211/48—N-alkylated amines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Forbindelser av formel (I) hvori R1 og R2 hver er valgt fra gruppen bestående av Cl-C4-lavere alkyl; X er NH eller S; og n er et helt tall innen om- rådet 1-4; og når n er O, er X (CH2)3, og farmasøytisk akseptable salter der- av, er blitt vist å være effektive ved behandling av tamoxifenresistente tumorer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94530592A | 1992-09-15 | 1992-09-15 | |
| PCT/US1993/007697 WO1994006762A1 (en) | 1992-09-15 | 1993-08-16 | Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO950985D0 NO950985D0 (no) | 1995-03-14 |
| NO950985L true NO950985L (no) | 1995-03-14 |
Family
ID=25482938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO950985A NO950985L (no) | 1992-09-15 | 1995-03-14 | Ikke-metaboliserbare klomifenanaloger for behandling av tamoxifenresistente tumorer |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US5410080A (no) |
| EP (1) | EP0660821B1 (no) |
| JP (1) | JPH09500863A (no) |
| KR (1) | KR100326962B1 (no) |
| AT (1) | ATE162516T1 (no) |
| AU (1) | AU672234B2 (no) |
| CA (1) | CA2143000C (no) |
| DE (1) | DE69316633T2 (no) |
| DK (1) | DK0660821T3 (no) |
| ES (1) | ES2112994T3 (no) |
| FI (1) | FI951193A7 (no) |
| GR (1) | GR3026236T3 (no) |
| HU (1) | HUT71244A (no) |
| NO (1) | NO950985L (no) |
| NZ (1) | NZ255785A (no) |
| WO (1) | WO1994006762A1 (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR008155A1 (es) * | 1996-09-06 | 1999-12-09 | Smithkline Beecham Corp | Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres. |
| CZ300929B6 (cs) * | 1997-08-15 | 2009-09-16 | Duke University | Sloucenina pro použití pri lécení nebo prevenci estrogenem stimulované rakoviny |
| UA113291C2 (xx) | 2011-08-04 | 2017-01-10 | Метаболіти транскломіфену і їх застосування | |
| CA2889770A1 (en) | 2012-11-02 | 2014-05-08 | Repros Therapeutics Inc. | Trans-clomiphene for use in cancer therapy |
| US9914696B2 (en) | 2014-03-11 | 2018-03-13 | Repros Therapeutics Inc. | Clomiphene synthesis using a single solvent |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2750416A (en) * | 1950-12-21 | 1956-06-12 | Rohm & Haas | Aminomethylphenols and method for their preparation |
| US3143568A (en) * | 1961-01-25 | 1964-08-04 | Vismara Francesco Spa | Diarylamino-acetyl-aryl derivatives |
| US3244705A (en) * | 1962-11-14 | 1966-04-05 | Richardson Merrell Inc | Triphenylhaloethylene derivatives |
| CH373975A (de) * | 1963-07-20 | 1963-12-15 | Heierle Werner | Kronen-Verschluss für Flaschen |
| FR3575M (fr) * | 1964-01-28 | 1965-10-04 | Richardson Merrell | Triphénylhalogénoéthylenes substitués. |
| US3631109A (en) * | 1968-12-04 | 1971-12-28 | Uniroyal Inc | Beta beta'-bis(dialkylaminomethyl-4-hydroxy-benzylthio)dialkylethers |
| GB2126576B (en) * | 1982-06-25 | 1985-06-19 | Farmos Group Limited | Alkane and alkene derivatives |
| GB2196003A (en) * | 1986-09-11 | 1988-04-20 | Nat Res Dev | Iodo-and bromo-tamoxifen derivatives |
| US5114951A (en) * | 1989-04-11 | 1992-05-19 | Burroughs Wellcome Company | Agents for combating multiple drug resistance |
| US5130424A (en) * | 1990-08-01 | 1992-07-14 | Merrell Dow Pharmaceuticals Inc. | 4-amino-delta-4,6-steroids and their use as 5 alpha-reductase inhibitors |
-
1993
- 1993-08-16 DK DK93920100T patent/DK0660821T3/da active
- 1993-08-16 AT AT93920100T patent/ATE162516T1/de not_active IP Right Cessation
- 1993-08-16 AU AU50150/93A patent/AU672234B2/en not_active Ceased
- 1993-08-16 EP EP93920100A patent/EP0660821B1/en not_active Expired - Lifetime
- 1993-08-16 NZ NZ255785A patent/NZ255785A/en unknown
- 1993-08-16 FI FI951193A patent/FI951193A7/fi not_active Application Discontinuation
- 1993-08-16 DE DE69316633T patent/DE69316633T2/de not_active Expired - Fee Related
- 1993-08-16 JP JP6508081A patent/JPH09500863A/ja not_active Ceased
- 1993-08-16 WO PCT/US1993/007697 patent/WO1994006762A1/en not_active Ceased
- 1993-08-16 KR KR1019950700991A patent/KR100326962B1/ko not_active Expired - Fee Related
- 1993-08-16 ES ES93920100T patent/ES2112994T3/es not_active Expired - Lifetime
- 1993-08-16 CA CA002143000A patent/CA2143000C/en not_active Expired - Fee Related
- 1993-08-16 HU HU9500775A patent/HUT71244A/hu unknown
-
1994
- 1994-02-10 US US08/196,817 patent/US5410080A/en not_active Expired - Fee Related
- 1994-12-05 US US08/350,192 patent/US5681863A/en not_active Expired - Fee Related
-
1995
- 1995-03-14 NO NO950985A patent/NO950985L/no not_active Application Discontinuation
-
1998
- 1998-02-25 GR GR980400417T patent/GR3026236T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994006762A1 (en) | 1994-03-31 |
| KR100326962B1 (ko) | 2002-12-02 |
| DE69316633D1 (de) | 1998-02-26 |
| DK0660821T3 (da) | 1998-09-21 |
| HU9500775D0 (en) | 1995-05-29 |
| FI951193L (fi) | 1995-03-14 |
| NZ255785A (en) | 1997-05-26 |
| AU672234B2 (en) | 1996-09-26 |
| ATE162516T1 (de) | 1998-02-15 |
| CA2143000C (en) | 2000-03-28 |
| FI951193A0 (fi) | 1995-03-14 |
| ES2112994T3 (es) | 1998-04-16 |
| AU5015093A (en) | 1994-04-12 |
| HUT71244A (en) | 1995-11-28 |
| DE69316633T2 (de) | 1998-05-20 |
| US5681863A (en) | 1997-10-28 |
| US5410080A (en) | 1995-04-25 |
| KR950703524A (ko) | 1995-09-20 |
| GR3026236T3 (en) | 1998-05-29 |
| JPH09500863A (ja) | 1997-01-28 |
| EP0660821A1 (en) | 1995-07-05 |
| NO950985D0 (no) | 1995-03-14 |
| CA2143000A1 (en) | 1994-03-31 |
| EP0660821B1 (en) | 1998-01-21 |
| FI951193A7 (fi) | 1995-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2153979A1 (en) | Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents | |
| MY102087A (en) | Phenethanolamine derivatives. | |
| EP0087098A3 (en) | S-triazine derivatives and their use as sunscreen agents | |
| CA2012686A1 (en) | Treatment and compounds | |
| MY101021A (en) | Novel compounds and compositions useful for producing analgesia. | |
| ES8303291A1 (es) | Un procedimiento para la preparacion de nuevos derivados de ariletanolamina. | |
| RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
| NO950985L (no) | Ikke-metaboliserbare klomifenanaloger for behandling av tamoxifenresistente tumorer | |
| ZA816259B (en) | 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants | |
| HUT62563A (en) | Process for producing 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydroproin derivatives and pharmaceutical compositions comprising same | |
| KR910004557A (ko) | 2,4,6-치환 페놀 유도체 | |
| FR2677983B1 (fr) | Composes alkylthiopoly(ethylimidazolium), procede de preparation et leur utilisation comme agents biocides. | |
| SE8205868D0 (sv) | A titre de medicaments, certains derives de lacide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant | |
| KR840005444A (ko) | 트리사이클릭 화합물의 제조방법 | |
| PT73331A (en) | Process for the preparation of propanolamine derivatives | |
| EP0134112A3 (en) | Pharmaceutical composition for prophylaxis or treatment of ketosis in livestock | |
| ES8605799A1 (es) | Procedimiento para la fabricacion de nuevos compuestos cinamoicos | |
| JPS52100470A (en) | Synthesis of hydantoin derivatives | |
| JPS5716852A (en) | Nitrile derivative, its preparation, and fibrosis suppressing agent containing the same | |
| IL69448A (en) | Process for combating phytopathogenic fungi with azolylphenoxy-tetrahydrofuran-2-ylidene methane derivatives | |
| SE8302452D0 (sv) | Method for treatment of senile dementia | |
| DE3175939D1 (en) | Use of gamma-piperidino-butyrophenones for the preparation of medicaments for treating diarrhoea | |
| SE8205767D0 (sv) | A titre de medicaments, certains derives mono substitues de lacide 4-phenyl 4-oxo buten-2-oigue, ainsi que les compositions les renfermant | |
| KR910000786A (ko) | 콜레스타디엔 유도체, 이의 제조방법 및 HMG-CoA 환원제를 저해하는 작용을 하는 약제로서의 이의 용도 | |
| JPS5430167A (en) | 4-aminomethyl-2-phenyloxazoles and their pharmaceutically acceptable acid salts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |